Navigation Links
Unisense FertiliTech A/S Secures an Additional 20 Million USD in New Capital Investment

AARHUS, Denmark, March 7, 2013 /PRNewswire/ --

Danish medtech company Unisense FertiliTech A/S announces a new partnership with the Danish Pension Fund PKA. PKA owns 25% of Unisense FertiliTech A/S after the purchase of shares in the company worth 20 million USD. This brings the total of new investment in the company over the past 3 months to 45 million USD.

Unisense FertiliTech A/S develops and manufactures products to improve treatment in the field of assisted reproduction. The company has expanded rapidly in the past 2 years, operating in more than 30 countries worldwide. In addition to the current hardware and software product offerings, there is an exciting pipeline of products under development which hold significant commercial potential within the IVF industry. With this additional investment, the company will be in an excellent position to execute its long term development strategy and to accelerate the global expansion of sales of FertiliTech's existing and new products geared towards improving clinical practice in the field of IVF.

Investment Director at PKA, Michael Nellemann Pedersen states "FertiliTech has created a unique product with a rapidly growing global demand. This demand is expected to continue, with a worldwide increased trend to a higher age of first time mothers.  We feel this is an extremely exciting investment opportunity with a promising future."

"We very much look forward to the cooperation with PKA, who with this long term investment contributes positively to create stability in the ownership of Unisense FertiliTech," says Unisense FertiliTech A/S CEO, Jens Gundersen .

About Unisense FertiliTech A/S  

Unisense FertiliTech A/S was founded in 2003 and has developed and manufactures state-of-the-art instrumentation in the field of IVF.  The current products include the EmbryoScope® Time-lapse system, the EmbryoViewer® Software and related accessory products, which are EU approved and FDA cleared for clinical use in IVF laboratories. Unisense FertiliTech A/S conforms to the requirements in DS/EN ISO 13485:2012 for production, installation and servicing of IVF incubators and related accessories

The company is involved in numerous international collaborations, and strives to develop embryo assessment algorithms to improve embryo selection and workflow in the assisted reproduction laboratory. Our goal is to promote knowledge building through extensive documentation and retrospective analysis. We are dedicated to providing technology to improve IVF treatment through quantification of embryo development patterns.

About PKA:

PKA is a joint administration for five Danish pension funds with a total of 250,000 members. They control funds of USD 35 billion.


SOURCE Unisense Fertilitech A/S
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Blue Marble Biomaterials Secures Distribution Agreement with SAFC
2. K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization
3. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
4. Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes
5. Amarantus BioSciences Secures $1.1 Million in Financing
6. Syngenta Secures EU Approval For Next Generation Fungicide
7. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
8. OncoSec Secures License for Electroporation Intellectual Property from University of South Florida
9. Bacterin Secures $25 Million Financing with OrbiMed
10. Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital
11. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: ) ... provide their customers enhanced security to access and ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):